Critical Roles for LIGHT and Its Receptors in Generating T Cell-Mediated Immunity during Infection

English version České info

LIGHT (TNFSF14) is a member of the TNF superfamily involved in inflammation and defence against infection. LIGHT signals via two cell-bound receptors; herpes virus entry mediator (HVEM) and lymphotoxin-beta receptor (LTβR). We found that LIGHT is critical for control of hepatic parasite growth in mice with visceral leishmaniasis (VL) caused by infection with the protozoan parasite Leishmania donovani. LIGHT-HVEM signalling is essential for early dendritic cell IL-12/IL-23p40 production, and the generation of IFNγ- and TNF-producing T cells that control hepatic infection. However, we also discovered that LIGHT-LTβR interactions suppress anti-parasitic immunity in the liver in the first 7 days of infection by mechanisms that restrict both CD4⁺ T cell function and TNF-dependent microbicidal mechanisms. Thus, we have identified distinct roles for LIGHT in infection, and show that manipulation of interactions between LIGHT and its receptors may be used for therapeutic advantage.

Vyšlo v časopise: Critical Roles for LIGHT and Its Receptors in Generating T Cell-Mediated Immunity during Infection. PLoS Pathog 7(10): e32767. doi:10.1371/journal.ppat.1002279
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002279

Souhrn

Zdroje

1. LocksleyRMKilleenNLenardoMJ 2001 The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104 487 501

2. AggarwalBB 2003 Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3 745 756

3. WareCF 2005 Network communications: lymphotoxins, LIGHT, and TNF. Annu Rev Immunol 23 787 819

4. WareCF 2008 Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways. Immunol Rev 223 186 201

5. AggarwalBBEessaluTEHassPE 1985 Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon. Nature 318 665 667

6. RuulsSRHoekRMNgoVNMcNeilTLucianLA 2001 Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity 15 533 543

7. MauriDNEbnerRMontgomeryRIKochelKDCheungTC 1998 LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 8 21 30

8. CrowePDVanArsdaleTLWalterBNWareCFHessionC 1994 A lymphotoxin-beta-specific receptor. Science 264 707 710

9. HarropJAMcDonnellPCBrigham-BurkeMLynSDMintonJ 1998 Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. J Biol Chem 273 27548 27556

10. ZhaiYGuoRHsuTLYuGLNiJ 1998 LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J Clin Invest 102 1142 1151

11. SedyJRGavrieliMPotterKGHurchlaMALindsleyRC 2005 B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol 6 90 98

12. CaiGAnumanthanABrownJAGreenfieldEAZhuB 2008 CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat Immunol 9 176 185

13. WhitbeckJCPengCLouHXuRWillisSH 1997 Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry. J Virol 71 6083 6093

14. MurphyTLMurphyKM 2010 Slow down and survive: Enigmatic immunoregulation by BTLA and HVEM. Annu Rev Immunol 28 389 411

15. CheungTCSteinbergMWOborneLMMacauleyMGFukuyamaS 2009 Unconventional ligand activation of herpesvirus entry mediator signals cell survival. Proc Natl Acad Sci U S A 106 6244 6249

16. OtterdalKSmithCOieEPedersenTMYndestadA 2006 Platelet-derived LIGHT induces inflammatory responses in endothelial cells and monocytes. Blood 108 928 935

17. KwonBSWangSUdagawaNHaridasVLeeZH 1998 TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption. Faseb J 12 845 854

18. MarstersSAAyresTMSkubatchMGrayCLRotheM 1997 Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1. J Biol Chem 272 14029 14032

19. BrowningJLSizingIDLawtonPBourdonPRRennertPD 1997 Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes. J Immunol 159 3288 3298

20. KabashimaKBanksTAAnselKMLuTTWareCF 2005 Intrinsic lymphotoxin-beta receptor requirement for homeostasis of lymphoid tissue dendritic cells. Immunity 22 439 450

21. SchneiderKLoewendorfADe TrezCFultonJRhodeA 2008 Lymphotoxin-mediated crosstalk between B cells and splenic stroma promotes the initial type I interferon response to cytomegalovirus. Cell Host Microbe 3 67 76

22. EhlersSHolscherCScheuSTertiltCHehlgansT 2003 The lymphotoxin beta receptor is critically involved in controlling infections with the intracellular pathogens Mycobacterium tuberculosis and Listeria monocytogenes. J Immunol 170 5210 5218

23. MurrayHWBermanJDDaviesCRSaraviaNG 2005 Advances in leishmaniasis. Lancet 366 1561 1577

24. StanleyACEngwerdaCR 2007 Balancing immunity and pathology in visceral leishmaniasis. Immunol Cell Biol 85 138 147

25. MurrayHWJungbluthARitterEMontelibanoCMarinoMW 2000 Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment. Infect Immun 68 6289 6293

26. EngwerdaCRAtoMStagerSAlexanderCEStanleyAC 2004 Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection. Am J Pathol 165 2123 2133

27. TumangMCKeoghCMoldawerLLHelfgottDCTeitelbaumR 1994 Role and effect of TNF-alpha in experimental visceral leishmaniasis. J Immunol 153 768 775

28. EngwerdaCRKayePM 2000 Organ-specific immune responses associated with infectious disease. Immunol Today 21 73 78

29. EngwerdaCRAtoMKayePM 2004 Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis. Trends Parasitol 20 524 530

30. KayePMSvenssonMAtoMMaroofAPolleyR 2004 The immunopathology of experimental visceral leishmaniasis. Immunol Rev 201 239 253

31. EngwerdaCRAtoMCotterellSEMynottTLTschannerlA 2002 A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infection. Am J Pathol 161 429 437

32. AtoMStagerSEngwerdaCRKayePM 2002 Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis. Nat Immunol 3 1185 1191

33. SquiresKESchreiberRDMcElrathMJRubinBYAndersonSL 1989 Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response. J Immunol 143 4244 4249

34. MurrayHWNathanCF 1999 Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J Exp Med 189 741 746

35. AnandSWangPYoshimuraKChoiIHHilliardA 2006 Essential role of TNF family molecule LIGHT as a cytokine in the pathogenesis of hepatitis. J Clin Invest 116 1045 1051

36. DejardinEDroinNMDelhaseMHaasECaoY 2002 The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17 525 535

37. De TrezCSchneiderKPotterKDroinNFultonJ 2008 The inhibitory HVEM-BTLA pathway counter regulates lymphotoxin receptor signaling to achieve homeostasis of dendritic cells. J Immunol 180 238 248

38. GorakPMEngwerdaCRKayePM 1998 Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. Eur J Immunol 28 687 695

39. EngwerdaCRMurphyMLCotterellSESmeltSCKayePM 1998 Neutralization of IL-12 demonstrates the existence of discrete organ- specific phases in the control of Leishmania donovani. Eur J Immunol 28 669 680

40. MurrayHW 1997 Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis. J Infect Dis 175 1477 1479

41. TrinchieriG 1995 Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13 251 276

42. PolleyRStagerSPrickettSMaroofAZubairiS 2006 Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen. Infect Immun 74 773 776

43. SmeltSCCotterellSEEngwerdaCRKayePM 2000 B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology. J Immunol 164 3681 3688

44. McElrathMJMurrayHWCohnZA 1988 The dynamics of granuloma formation in experimental visceral leishmaniasis. J Exp Med 167 1927 1937

45. AlexanderCEKayePMEngwerdaCR 2001 CD95 is required for the early control of parasite burden in the liver of Leishmania donovani-infected mice. Eur J Immunol 31 1199 1210

46. TamadaKShimozakiKChapovalAIZhaiYSuJ 2000 LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J Immunol 164 4105 4110

47. TamadaKShimozakiKChapovalAIZhuGSicaG 2000 Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway. Nat Med 6 283 289

48. WangJLoJCFosterAYuPChenHM 2001 The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT. J Clin Invest 108 1771 1780

49. ShaikhRBSanteeSGrangerSWButrovichKCheungT 2001 Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction. J Immunol 167 6330 6337

50. EngwerdaCRSmeltSCKayePM 1996 An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice. Exp Parasitol 84 195 202

51. XuGLiuDOkworIWangYKornerH 2007 LIGHT Is critical for IL-12 production by dendritic cells, optimal CD4+ Th1 cell response, and resistance to Leishmania major. J Immunol 179 6901 6909

52. RandallLMAmanteFHZhouYStanleyACHaqueA 2008 Cutting edge: selective blockade of LIGHT-lymphotoxin beta receptor signaling protects mice from experimental cerebral malaria caused by Plasmodium berghei ANKA. J Immunol 181 7458 7462

53. LuBRutledgeBJGuLFiorilloJLukacsNW 1998 Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 187 601 608

54. GeissmannFAuffrayCPalframanRWirrigCCioccaA 2008 Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol Cell Biol 86 398 408

55. CheongCMatosIChoiJHDandamudiDBShresthaE 2010 Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell 143 416 429

56. MombaertsPIacominiJJohnsonRSHerrupKTonegawaS 1992 RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68 869 877

57. ScheuSAlferinkJPotzelTBarchetWKalinkeU 2002 Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis. J Exp Med 195 1613 1624

58. KornerHCookMRimintonDSLemckertFAHoekRM 1997 Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur J Immunol 27 2600 2609

59. BarndenMJAllisonJHeathWRCarboneFR 1998 Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol 76 34 40

60. HogquistKAJamesonSCHeathWRHowardJLBevanMJ 1994 T cell receptor antagonist peptides induce positive selection. Cell 76 17 27

61. DaltonDKPitts-MeekSKeshavSFigariISBradleyA 1993 Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259 1739 1742

62. CuiJShinTKawanoTSatoHKondoE 1997 Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278 1623 1626

63. StanleyACDaltonJERossottiSHMacDonaldKPZhouY 2008 VCAM-1 and VLA-4 modulate dendritic cell IL-12p40 production in experimental visceral leishmaniasis. PLoS Pathog 4 e1000158

64. HaqueAStanleyACAmanteFHRivera FdeLZhouY 2010 Therapeutic glucocorticoid-induced TNF receptor-mediated amplification of CD4+ T cell responses enhances antiparasitic immunity. J Immunol 184 2583 2592

65. StanleyACZhouYAmanteFHRandallLMHaqueA 2008 Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis. PLoS Pathog 4 e1000028

66. SanjoHZajoncDMBradenRNorrisPSWareCF 2010 Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor. J Biol Chem 285 17148 17155